XML 17 R24.htm IDEA: XBRL DOCUMENT v3.19.3
Asset Acquisitions and Contingent Consideration (Tables)
9 Months Ended
Sep. 30, 2019
Business Combinations [Abstract]  
Schedule of IPR&D Expense

The Company recorded the following IPR&D expense on the condensed consolidated statements of operations (in thousands):

 

 

 

Three months ended September 30,

 

 

Nine months ended September 30,

 

 

 

2019

 

 

2018

 

 

2019

 

 

2018

 

GB001

 

$

 

 

$

 

 

$

 

 

$

19,148

 

GB004

 

 

 

 

 

 

 

 

 

 

 

20,000

 

GB1275

 

 

 

 

 

7,500

 

 

 

1,000

 

 

 

7,500

 

Other Programs

 

 

 

 

 

761

 

 

 

1,000

 

 

 

3,011

 

Total in process research and development

 

$

 

 

$

8,261

 

 

$

2,000

 

 

$

49,659